Company News, Regulations

FDA Issues Warning Letters

Dr. Brandt and Episcience hear from the Agency.

Author Image

By: TOM BRANNA

Editor

The US Food and Drug Administration issued Warning Letters to two cosmetics companies,  Dr. Brandt Skin Care and Episciences, Inc., earlier this month for making unapproved drug claims under the Federal Food, Drug and Cosmetic Act. FDA took exception to claims on Dr. Brandt's website that included: • “(B)oosts collagen production…” for the Glow product line (Overnight Resurfacing Serum, Ruby Crystal Retinol Hydracrème, Revitalizing Retinol Eye Cream, Glow by Dr. Trandt t...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters